October 21, 2016 8:05 PM ET


Company Overview of Ohr Pharmaceutical, Inc.

Executive Profile

Jason Scott Slakter M.D.

Chief Executive Officer and Director, Ohr Pharmaceutical, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Jason Scott Slakter, M.D., has been the Chief Executive Officer of Ohr Pharmaceutical, Inc. since September 2015. Dr. Slakter served as the Chief Medical Officer of Ohr Pharmaceutical, Inc. from May 2014 to August 7, 2015. He co-founded SKS Ocular, LLC in 2010 and served as its Chief Executive Officer. Dr. Slakter served as the Clinical Advisor of Acucela Inc. He served as Chief Medical Officer of Potentia Pharmaceuticals, Inc. He serves as an Editor-in-Chief of ...

Corporate Headquarters

800 Third Avenue
New York, New York 10022

United States

Phone: 212-682-8452
Fax: --

Board Members Memberships

Chief Executive Officer and Director


There is no Education data available.

Other Affiliations

Annual Compensation

Total Annual Compensation$200,000

Stocks Options

Restricted Stock Awards$163,333
Exercisable Options$12,500
Unexercisable Options$37,500
Total Number of Options$50,000

Total Compensation

Total Annual Cash Compensation$200,000
Total Short Term Compensation$200,000
Other Long Term Compensation$163,333
Total Calculated Compensation$610,622

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ohr Pharmaceutical, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.